Elder Pharmaceuticals' promoter group - Semit Pharmaceuticals Chemicals have pledged an additional 10 lakh shares of the company on September 19, 2011 to be worth around Rs 37.56 crore. Post transaction, the total number of pledged shares stood at 19.43 lakhs, aggregating 9.46% stake in the company.
Recently, the company was likely to introduce 12 new products this fiscal in the areas of gynaecology, pain management and nutraceuticals. The company had aimed 15 products for this financial year, three have already been launched and it is looking at another 12 products for the next three quarters.
Elder Pharmaceuticals manufactures and markets prescription pharmaceutical brands, surgical and medical devices.
